Pathological response and survival in triple-negative breast cancer following neoadjuvant carboplatin plus docetaxel

PURPOSE: Prognostic value of pCR and extent of pathological response attained with anthracycline-free platinum plus taxane neoadjuvant chemotherapy (NAC) in TNBC is unknown. We report recurrence-free survival (RFS) and overall survival (OS) according to degree of pathological response in patients tr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Sharma, Priyanka, López-Tarruella, Sara, García-Saenz, José Angel, Khan, Qamar J., Gómez, Henry L., Prat, Aleix, Moreno, Fernando, Jerez-Gilarranz, Yolanda, Barnadas, Agustí, Picornell, Antoni C., del Monte-Millán, María, González-Rivera, Milagros, Massarrah, Tatiana, Pelaez-Lorenzo, Beatriz, Palomero, María Isabel, González del Val, Ricardo, Cortés, Javier, Rivera, Hugo Fuentes, Morales, Denisse Bretel, Márquez-Rodas, Iván, Perou, Charles M., Lehn, Carolyn, Wang, Yen Y., Klemp, Jennifer R., Mammen, Joshua V., Wagner, Jamie L., Amin, Amanda L., O’Dea, Anne P., Heldstab, Jaimie, Jensen, Roy A., Kimler, Bruce F., Godwin, Andrew K., Martín, Miguel
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6279513/
https://ncbi.nlm.nih.gov/pubmed/30061361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-0585
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados